This new position paper proposes 5 pre-defined business priorities to help pharma affiliates adjust to the changes of HCPs expectations, so that to keep them engaged in the post-Covid-19 era.
News
This new position paper analyses the current market segment situation and estimates its perspectives of evolution. Thus,...
With 3 million people affected in France, rare diseases are a major public health issue. 25% of...
This position paper covers the following key issues: